Agents for the Treatment of Heparin-Induced Thrombocytopenia-Reference-Cited by-同舟云学术

Agents for the Treatment of Heparin-Induced Thrombocytopenia

Published:2010-08 Issue:4 Volume:24 Page:755-775
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Warkentin Theodore E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference76 articles.

1. A 14-year study of heparin-induced thrombocytopenia;Warkentin;Am J Med,1996

2. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients;Greinacher;Thromb Haemost,2005

3. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh ACCP conference on antithrombotic and thrombolytic therapy;Warkentin;Chest,2004

4. Treatment and prevention of heparin-induced thrombocytopenia. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition);Warkentin;Chest,2008

5. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia;Wallis;Am J Med,1999

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Heparin-Induced Thrombocytopenia;Journal of Clinical Medicine;2023-11-03

2. Immunologic Effects of Heparin Associated With Hemodialysis: Focus on Heparin-Induced Thrombocytopenia;Seminars in Nephrology;2023-11

3. Heparine und andere parenterale Antikoagulanzien;Klinische Angiologie;2023

4. Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study;Journal of Thrombosis and Haemostasis;2022-11

5. Platelet-activating anti-PF4 disorders: An overview;Seminars in Hematology;2022-04